Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism

Bone

Volumn 48, Issue 3, 2011, Pages 557-561

  Stein, Emily M ^a   Dempster, David W ^b   Udesky, Julia ^a   Zhou, Hua ^b   Bilezikian, John P ^a   Shane, Elizabeth ^a   Silverberg, Shonni J ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b HELEN HAYES HOSPITAL   (United States)

Author keywords

Cortical bone; Histomorphometry; Primary hyperparathyroidism; Secondary hyperparathyroidism; Vitamin D deficiency

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE; BONE BIOPSY; BONE REMODELING; BONE VOLUME; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CORTICAL BONE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; ORGAN SIZE; POROSITY; PRIMARY HYPERPARATHYROIDISM; TRABECULAR BONE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

BONE AND BONES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79751535233     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.10.004     Document Type: Article

References (29)

1. Silverberg S.J., Shane E., Dempster D.W., Bilezikian J.P. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999, 107:561-567.
2. Boudou P., Ibrahim F., Cormier C., Sarfati E., Souberbielle J.C. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 2006, 29:511-515.
3. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000, 85:1054-1058.
4. Nordenstrom E., Westerdahl J., Lindergard B., Lindblom P., Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 2002, 26:1463-1467.
5. Rao D.S., Agarwal G., Talpos G.B., Phillips E.R., Bandeira F., Mishra S.K., et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 2002, 17(Suppl 2):N75-N80.
6. Parfitt A.M. Parathyroid growth: normal and abnormal. The parathyroids: basic and clinical concepts 2001, 293-330. Academic Press, New York. J.P. Bilezikian, M.A. Levine, R. Marcus (Eds.).
7. Mosekilde L., Charles P., Lindegreen P. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone Miner 1989, 5:279-290.
8. Clements M.R., Davies M., Fraser D.R., Lumb G.A., Mawer E.B., Adams P.H. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond) 1987, 73:659-664.
9. Silverberg S.J., Shane E., de la Cruz L., Dempster D.W., Feldman F., Seldin D., et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989, 4:283-291.
10. Parisien M., Mellish R.W., Silverberg S.J., Shane E., Lindsay R., Bilezikian J.P., et al. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 1992, 7:913-919.
11. Parisien M., Cosman F., Mellish R.W., Schnitzer M., Nieves J., Silverberg S.J., et al. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 1995, 10:1393-1399.
12. Parisien M., Silverberg S.J., Shane E., de la Cruz L., Lindsay R., Bilezikian J.P., et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990, 70:930-938.
13. Dempster D.W., Parisien M., Silverberg S.J., Liang X.G., Schnitzer M., Shen V., et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 1999, 84:1562-1566.
14. Dempster D.W., Muller R., Zhou H., Kohler T., Shane E., Parisien M., et al. Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 2007, 41:19-24.
15. Christiansen P., Steiniche T., Brixen K., Hessov I., Melsen F., Charles P., et al. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997, 21:93-99.
16. Brockstedt H., Christiansen P., Mosekilde L., Melsen F. Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 1995, 16:109-117.
17. Christiansen P., Steiniche T., Brockstedt H., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism: iliac crest cortical thickness, structure and remodeling evaluated by histomorphometric methods. Aarhus Bone and Mineral Research Group. Bone 1993, 14:403-408.
18. Christiansen P., Steiniche T., Vesterby A., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992, 13:41-49.
19. Steiniche T., Christiansen P., Vesterby A., Ullerup R., Hessov I., Mosekilde L.E., et al. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3years after surgical treatment. Bone 2000, 26:535-543.
20. Parisien M., Silverberg S.J., Shane E., de la C.L., Lindsay R., Bilezikian J.P., et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990, 70:930-938.
21. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999, 341:1249-1255.
22. Rubin M.R., Bilezikian J.P., McMahon D.J., Jacobs T., Shane E., Siris E., et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15years. J Clin Endocrinol Metab 2008, 93:3462-3470.
23. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
24. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009, 94:335-339.
25. Parfitt A.M., Qiu S., Rao D.S. The mineralization index-a new approach to the histomorphometric appraisal of osteomalacia. Bone 2004, 35:320-325.
26. Compston J. Vitamin D. Bone histomorphometry 1997, 573-586. Academic Press, New York. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
27. Orwoll E.S., McClung M.R., Oviatt S.K., Recker R.R., Weigel R.M. Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis. J Bone Miner Res 1989, 4:81-88.
28. Need A.G., Horowitz M., Morris H.A., Moore R., Nordin C. Seasonal change in osteoid thickness and mineralization lag time in ambulant patients. J Bone Miner Res 2007, 22:757-761.
29. Armas L., Heaney R.P., Recker R.R. Seasonal variation in bone histomorphometry. J Bone Miner Res 2008, 23:301. author reply 301.